Clinical Trials Browser

Phase 2 × Non-small Cell Lung Cancer Metastatic × necitumumab × Clear all

NCT02443337 2020-12-09

A Study of LY3023414 and Necitumumab in Squamous Lung Cancer

Phase 2 Terminated

31 enrolled 14 charts

Non-small Cell Lung Cancer Metastatic